The delta opioid receptor subtypes and pain modulation

Michael H. Ossipov, Josephine Lai, Todd W Vanderah, Frank Porreca

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

The existence of endogenous receptors for opioids in 1973 [1-3] ignited the vigorous search for endogenous substances that act at these receptor sites. Furthermore, the existence of these receptors generated great interest in the exploration of endogenous pain mechanisms and modulation by inhibitory systems, as well as into biological mechanisms of opiate dependence and withdrawal. Recognition of the strong likelihood of multiple subtypes of opioid receptors came from the work of Martin [4]. It was found that vastly different behavioral syndromes were elicited in spinalized dogs by morphine, ketocyclazocine, and SKF-10,047 leading to the nomenclature of mu, kappa, and sigma opiate receptors, respectively [4,5]. The observation of differential binding affnities for [Met5]enkephalin and h endorphin against [3H][Leu5] enkephalin and [3H]naloxone in guinea pig brain and differential agonistic activity profiles of [Leu5]enkephalin and [Met5]enkephalin in the isolated mouse vas deferens and guinea pig ileum strongly supported the existence of the y-opioid receptor [6-8]. Over time, the existence of additional opioid receptor subtypes has been hypothesized to include the epsilon receptor [9] and possibly others. The actual characterization of these additional receptors has not been achieved, and with the advent of molecular cloning of the opioid receptors, only three subtypes are generally accepted; namely, the mu, kappa, and delta (y) subtypes [10]. The existence of subtypes of these opioid receptors, including the y-opioid receptor have also been suggested, based on a broad array of approaches including pharmacological and receptor binding studies. Although different subtypes have not been cloned, it is possible for example that posttranscriptional events may occur to produce these subtypes [10]. Here, the pharmacology and physiology of the y-opioid receptors is discussed.

Original languageEnglish (US)
Title of host publicationThe Delta Receptor
PublisherCRC Press
Pages297-329
Number of pages33
ISBN (Electronic)9780203025765
ISBN (Print)9780824740313
StatePublished - Jan 1 2003

Fingerprint

delta Opioid Receptor
Opioid Receptors
Pain
Enkephalins
Guinea Pigs
Pharmacology
sigma Receptors
Endorphins
Opioid-Related Disorders
Vas Deferens
Molecular Cloning
Naloxone
Ileum
Terminology
Morphine
Observation
Dogs

ASJC Scopus subject areas

  • Neuroscience(all)
  • Health Professions(all)
  • Medicine(all)

Cite this

Ossipov, M. H., Lai, J., Vanderah, T. W., & Porreca, F. (2003). The delta opioid receptor subtypes and pain modulation. In The Delta Receptor (pp. 297-329). CRC Press.

The delta opioid receptor subtypes and pain modulation. / Ossipov, Michael H.; Lai, Josephine; Vanderah, Todd W; Porreca, Frank.

The Delta Receptor. CRC Press, 2003. p. 297-329.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ossipov, MH, Lai, J, Vanderah, TW & Porreca, F 2003, The delta opioid receptor subtypes and pain modulation. in The Delta Receptor. CRC Press, pp. 297-329.
Ossipov MH, Lai J, Vanderah TW, Porreca F. The delta opioid receptor subtypes and pain modulation. In The Delta Receptor. CRC Press. 2003. p. 297-329
Ossipov, Michael H. ; Lai, Josephine ; Vanderah, Todd W ; Porreca, Frank. / The delta opioid receptor subtypes and pain modulation. The Delta Receptor. CRC Press, 2003. pp. 297-329
@inbook{c75ca4777f17401c8025117254484c05,
title = "The delta opioid receptor subtypes and pain modulation",
abstract = "The existence of endogenous receptors for opioids in 1973 [1-3] ignited the vigorous search for endogenous substances that act at these receptor sites. Furthermore, the existence of these receptors generated great interest in the exploration of endogenous pain mechanisms and modulation by inhibitory systems, as well as into biological mechanisms of opiate dependence and withdrawal. Recognition of the strong likelihood of multiple subtypes of opioid receptors came from the work of Martin [4]. It was found that vastly different behavioral syndromes were elicited in spinalized dogs by morphine, ketocyclazocine, and SKF-10,047 leading to the nomenclature of mu, kappa, and sigma opiate receptors, respectively [4,5]. The observation of differential binding affnities for [Met5]enkephalin and h endorphin against [3H][Leu5] enkephalin and [3H]naloxone in guinea pig brain and differential agonistic activity profiles of [Leu5]enkephalin and [Met5]enkephalin in the isolated mouse vas deferens and guinea pig ileum strongly supported the existence of the y-opioid receptor [6-8]. Over time, the existence of additional opioid receptor subtypes has been hypothesized to include the epsilon receptor [9] and possibly others. The actual characterization of these additional receptors has not been achieved, and with the advent of molecular cloning of the opioid receptors, only three subtypes are generally accepted; namely, the mu, kappa, and delta (y) subtypes [10]. The existence of subtypes of these opioid receptors, including the y-opioid receptor have also been suggested, based on a broad array of approaches including pharmacological and receptor binding studies. Although different subtypes have not been cloned, it is possible for example that posttranscriptional events may occur to produce these subtypes [10]. Here, the pharmacology and physiology of the y-opioid receptors is discussed.",
author = "Ossipov, {Michael H.} and Josephine Lai and Vanderah, {Todd W} and Frank Porreca",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824740313",
pages = "297--329",
booktitle = "The Delta Receptor",
publisher = "CRC Press",

}

TY - CHAP

T1 - The delta opioid receptor subtypes and pain modulation

AU - Ossipov, Michael H.

AU - Lai, Josephine

AU - Vanderah, Todd W

AU - Porreca, Frank

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The existence of endogenous receptors for opioids in 1973 [1-3] ignited the vigorous search for endogenous substances that act at these receptor sites. Furthermore, the existence of these receptors generated great interest in the exploration of endogenous pain mechanisms and modulation by inhibitory systems, as well as into biological mechanisms of opiate dependence and withdrawal. Recognition of the strong likelihood of multiple subtypes of opioid receptors came from the work of Martin [4]. It was found that vastly different behavioral syndromes were elicited in spinalized dogs by morphine, ketocyclazocine, and SKF-10,047 leading to the nomenclature of mu, kappa, and sigma opiate receptors, respectively [4,5]. The observation of differential binding affnities for [Met5]enkephalin and h endorphin against [3H][Leu5] enkephalin and [3H]naloxone in guinea pig brain and differential agonistic activity profiles of [Leu5]enkephalin and [Met5]enkephalin in the isolated mouse vas deferens and guinea pig ileum strongly supported the existence of the y-opioid receptor [6-8]. Over time, the existence of additional opioid receptor subtypes has been hypothesized to include the epsilon receptor [9] and possibly others. The actual characterization of these additional receptors has not been achieved, and with the advent of molecular cloning of the opioid receptors, only three subtypes are generally accepted; namely, the mu, kappa, and delta (y) subtypes [10]. The existence of subtypes of these opioid receptors, including the y-opioid receptor have also been suggested, based on a broad array of approaches including pharmacological and receptor binding studies. Although different subtypes have not been cloned, it is possible for example that posttranscriptional events may occur to produce these subtypes [10]. Here, the pharmacology and physiology of the y-opioid receptors is discussed.

AB - The existence of endogenous receptors for opioids in 1973 [1-3] ignited the vigorous search for endogenous substances that act at these receptor sites. Furthermore, the existence of these receptors generated great interest in the exploration of endogenous pain mechanisms and modulation by inhibitory systems, as well as into biological mechanisms of opiate dependence and withdrawal. Recognition of the strong likelihood of multiple subtypes of opioid receptors came from the work of Martin [4]. It was found that vastly different behavioral syndromes were elicited in spinalized dogs by morphine, ketocyclazocine, and SKF-10,047 leading to the nomenclature of mu, kappa, and sigma opiate receptors, respectively [4,5]. The observation of differential binding affnities for [Met5]enkephalin and h endorphin against [3H][Leu5] enkephalin and [3H]naloxone in guinea pig brain and differential agonistic activity profiles of [Leu5]enkephalin and [Met5]enkephalin in the isolated mouse vas deferens and guinea pig ileum strongly supported the existence of the y-opioid receptor [6-8]. Over time, the existence of additional opioid receptor subtypes has been hypothesized to include the epsilon receptor [9] and possibly others. The actual characterization of these additional receptors has not been achieved, and with the advent of molecular cloning of the opioid receptors, only three subtypes are generally accepted; namely, the mu, kappa, and delta (y) subtypes [10]. The existence of subtypes of these opioid receptors, including the y-opioid receptor have also been suggested, based on a broad array of approaches including pharmacological and receptor binding studies. Although different subtypes have not been cloned, it is possible for example that posttranscriptional events may occur to produce these subtypes [10]. Here, the pharmacology and physiology of the y-opioid receptors is discussed.

UR - http://www.scopus.com/inward/record.url?scp=85044691615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044691615&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85044691615

SN - 9780824740313

SP - 297

EP - 329

BT - The Delta Receptor

PB - CRC Press

ER -